Waters... noitazilaicremmoC dna tnempole

Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists
Policy & Regulation
上一篇:Next's... remmus dna gnirps rof 'thgil d
下一篇:What... ?otpyrc ni covah gnisuac ti si